Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,875 | 3 | 41.9% |
| Honoraria | $2,800 | 2 | 24.1% |
| Food and Beverage | $2,716 | 98 | 23.4% |
| Travel and Lodging | $1,029 | 2 | 8.8% |
| Education | $210.79 | 5 | 1.8% |
| Unspecified | $0 | 9 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Myovant Sciences Inc. | $5,012 | 12 | $0 (2022) |
| UroGPO LLC | $3,773 | 13 | $0 (2020) |
| SN Holdings, LLC | $917.41 | 10 | $0 (2024) |
| ABBVIE INC. | $251.00 | 13 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $245.23 | 11 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $170.48 | 6 | $0 (2024) |
| Janssen Biotech, Inc. | $151.41 | 8 | $0 (2024) |
| Astellas Pharma US Inc | $128.35 | 4 | $0 (2023) |
| Coloplast Corp | $121.28 | 2 | $0 (2017) |
| Boston Scientific Corporation | $83.85 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $333.95 | 16 | ABBVIE INC. ($98.70) |
| 2023 | $497.23 | 21 | Astellas Pharma US Inc ($99.79) |
| 2022 | $444.01 | 27 | ABBVIE INC. ($76.52) |
| 2021 | $5,859 | 14 | Myovant Sciences Inc. ($4,945) |
| 2020 | $92.74 | 5 | UroGPO LLC ($81.72) |
| 2019 | $276.70 | 11 | UroGPO LLC ($114.54) |
| 2018 | $3,804 | 11 | UroGPO LLC ($3,576) |
| 2017 | $323.94 | 14 | Coloplast Corp ($121.28) |
All Payment Transactions
119 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $30.20 | General |
| 10/23/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/12/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: ONCOLOGY | ||||||
| 07/31/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/08/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: HORMONE THERAPY | ||||||
| 06/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $30.98 | General |
| Category: Oncology | ||||||
| 04/01/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/28/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $76.04 | General |
| Category: UROLOGY | ||||||
| 02/06/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Oncology | ||||||
| 2024 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 2024 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 12/18/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: HORMONE THERAPY | ||||||
| 12/05/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/26/2023 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Oncology | ||||||
| 10/23/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: Oncology | ||||||
| 10/17/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: HORMONE THERAPY | ||||||
| 10/03/2023 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 07/24/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Oncology | ||||||
| 07/12/2023 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $48.47 | General |
| Category: LithoVue_URO | ||||||
| 07/05/2023 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 2,180 | 5,444 | $680,896 | $209,968 |
| 2022 | 29 | 2,102 | 7,493 | $619,178 | $179,363 |
| 2021 | 26 | 2,064 | 5,877 | $372,575 | $96,129 |
| 2020 | 28 | 1,845 | 4,614 | $362,193 | $90,105 |
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2023 | 52 | 168 | $189,840 | $42,847 | 22.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 12 | 2,040 | $102,000 | $37,919 | 37.2% |
| 55874 | Injection of biodegradable material next to prostate | Office | 2023 | 13 | 13 | $95,378 | $26,454 | 27.7% |
| A4648 | Tissue marker, implantable, any type, each | Office | 2023 | 25 | 76 | $27,500 | $21,560 | 78.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 138 | 220 | $55,000 | $18,576 | 33.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 18 | 117 | $67,041 | $15,633 | 23.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 908 | 1,287 | $15,444 | $10,776 | 69.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 138 | 156 | $27,300 | $8,360 | 30.6% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 207 | 281 | $12,926 | $5,049 | 39.1% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 11 | 68 | $8,636 | $3,121 | 36.1% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 66 | 106 | $6,890 | $2,635 | 38.2% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 20 | 39 | $10,062 | $2,349 | 23.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 36 | 44 | $20,460 | $2,227 | 10.9% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 11 | 91 | $5,824 | $2,126 | 36.5% |
| 55876 | Placement of device in prostate for radiation therapy | Office | 2023 | 25 | 25 | $10,000 | $2,033 | 20.3% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 41 | $5,863 | $1,838 | 31.3% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 12 | 17 | $2,975 | $1,045 | 35.1% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 247 | 319 | $2,552 | $984.07 | 38.6% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 17 | 34 | $3,400 | $772.46 | 22.7% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 11 | 13 | $1,638 | $576.55 | 35.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 26 | 53 | $1,431 | $548.55 | 38.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 33 | 67 | $1,340 | $509.87 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 11 | 11 | $1,925 | $507.10 | 26.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 27 | 45 | $1,348 | $464.85 | 34.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 57 | 63 | $2,520 | $418.32 | 16.6% |
About Dr. John Greer, M.D
Dr. John Greer, M.D is a Urology healthcare provider based in Meridian, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356393227.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Greer, M.D has received a total of $11,631 in payments from pharmaceutical and medical device companies, with $333.95 received in 2024. These payments were reported across 119 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($4,875).
As a Medicare-enrolled provider, Greer has provided services to 8,191 Medicare beneficiaries, totaling 23,428 services with total Medicare billing of $575,564. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Meridian, ID
- Active Since 05/17/2006
- Last Updated 02/22/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1356393227
Products in Payments
- ORGOVYX (Drug) $5,107
- Nubeqa (Drug) $198.89
- BOTOX (Biological) $171.32
- Erleada (Drug) $129.53
- PENILE & TESTICULAR RECONSTRUCTN (Device) $121.28
- XTANDI (Drug) $109.36
- ZYTIGA (Drug) $104.24
- GEMTESA (Drug) $89.06
- Axumin (Drug) $72.33
- LUPRON DEPOT (Drug) $60.75
- XGEVA (Biological) $53.29
- KEYTRUDA (Biological) $53.04
- PROVENGE (Drug) $52.25
- LithoVue (Device) $48.47
- Xofigo (Drug) $46.34
- Urolift - UL400 (Device) $46.06
- SpaceOAR VUE System - 10mL (Device) $35.38
- UROLIFT (Device) $32.37
- XIAFLEX (Biological) $28.36
- Xtandi (Drug) $25.52
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Meridian
Dr. Maggie Vuturo, Md, MD
Urology — Payments: $14,498
Dr. Brian Auge, Md, MD
Urology — Payments: $7,062
Dr. Wade Muncey, M.d, M.D
Urology — Payments: $6,979
Dr. Michael Jacobson, M.d, M.D
Urology — Payments: $6,965
Dr. Dawn King, M.d, M.D
Urology — Payments: $6,832
Dr. Todd Waldmann, M.d, M.D
Urology — Payments: $6,668